{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:41:27Z","timestamp":1791258087558,"version":"4.1.0"},"reference-count":38,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["NWA.1160.18.300"],"award-info":[{"award-number":["NWA.1160.18.300"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Approximately 10% of chronic pain patients who receive opioids develop an opioid use disorder (OUD). Tapering programmes for these patients show high drop-out rates. Insight into chronic pain patients\u2019 experiences with tapering programmes for prescription OUD could help improve such programmes. Therefore, we investigated the perspectives of chronic pain patients with prescription OUD to identify facilitators and barriers to initiate and complete a specialised OUD tapering programme.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A qualitative study using semi-structured interviews on experiences with initiation and completion of opioid tapering was audio recorded, transcribed and subject to directed content analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>This study was conducted in two facilities with specialised opioid tapering programmes in the Netherlands.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Twenty-five adults with chronic pain undergoing treatment for prescription OUD participated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Participants indicated that tapering is a personal process, where willingness and motivation to taper, perceived (medical) support and pain coping strategies have an impact on the tapering outcome. The opportunity to join a medical-assisted tapering programme, shared decision-making regarding tapering pace, tapering location, and receiving medical and psychological support facilitated completion of an opioid tapering programme.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>According to patients, a successful treatment of prescription OUD requires a patient-centred approach that combines personal treatment goals with shared decision-making on opioid tapering. Referral to a specialised tapering programme that incorporates opioid rotation, non-judgmental attitudes, and psychological support can create a safe and supportive environment, fostering successful tapering and recovery.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2023-075246","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T18:22:11Z","timestamp":1702146131000},"page":"e075246","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Patients\u2019 perspectives on tapering programmes for prescription opioid use disorder: a qualitative study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-9111","authenticated-orcid":false,"given":"Lisa Eveline Maria","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen S","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katinka FM","family":"Damen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmen","family":"Beurmanjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne WT","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel L","family":"Bouvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnt FA","family":"Schellekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,9]]},"reference":[{"key":"2023120910202707000_13.12.e075246.1","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1016\/S2468-2667(19)30156-2","article-title":"Are we facing an opioid crisis in Europe?","volume":"4","author":"Verhamme","year":"2019","journal-title":"Lancet Public Health"},{"key":"2023120910202707000_13.12.e075246.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2008.11.006"},{"key":"2023120910202707000_13.12.e075246.3","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S2468-2667(19)30128-8","article-title":"Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study","volume":"4","author":"Kalkman","year":"2019","journal-title":"Lancet Public Health"},{"key":"2023120910202707000_13.12.e075246.4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FTD.0000000000000789","article-title":"Is Europe facing an emerging opioid crisis comparable to the US","volume":"43","author":"van Amsterdam","year":"2021","journal-title":"Ther Drug Monit"},{"key":"2023120910202707000_13.12.e075246.5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/epirev\/mxaa012","article-title":"The worldwide opioid pandemic: epidemiologic perspectives","volume":"42","author":"Celentano","year":"2020","journal-title":"Epidemiol Rev"},{"key":"2023120910202707000_13.12.e075246.6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2147\/JPR.S47182","article-title":"Long-term opioid treatment of chronic nonmalignant pain: Unproven efficacy and neglected safety?","volume":"6","author":"Kissin","year":"2013","journal-title":"J Pain Res"},{"key":"2023120910202707000_13.12.e075246.7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-5-201109060-00011"},{"key":"2023120910202707000_13.12.e075246.8"},{"key":"2023120910202707000_13.12.e075246.9","doi-asserted-by":"crossref","unstructured":"Bedene A , van Dorp ELA , Faquih T , et al . Causes and consequences of the opioid epidemic in the Netherlands: a population-based cohort study. Sci Rep 2020;10:15309. doi:10.1038\/s41598-020-72084-6","DOI":"10.1038\/s41598-020-72084-6"},{"key":"2023120910202707000_13.12.e075246.10","doi-asserted-by":"crossref","unstructured":"Els C , Jackson TD , Kunyk D , et al . Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane reviews. Cochrane Database Syst Rev 2017;10:CD012509. doi:10.1002\/14651858.CD012509.pub2","DOI":"10.1002\/14651858.CD012509"},{"key":"2023120910202707000_13.12.e075246.11","doi-asserted-by":"publisher","DOI":"10.1097\/01.j.pain.0000460357.01998.f1"},{"key":"2023120910202707000_13.12.e075246.12","doi-asserted-by":"crossref","unstructured":"Association AP . Diagnostic and statistical Manual of mental disorders. In: Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). American Psychiatric Pub, 2013. doi:10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2023120910202707000_13.12.e075246.13","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170363"},{"key":"2023120910202707000_13.12.e075246.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2018.09.001"},{"key":"2023120910202707000_13.12.e075246.15","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/pm\/pnw078","article-title":"Patients\u2019 perspectives on tapering of chronic opioid therapy: a qualitative study","volume":"17","author":"Frank","year":"2016","journal-title":"Pain Med"},{"key":"2023120910202707000_13.12.e075246.16","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0598"},{"key":"2023120910202707000_13.12.e075246.17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/j.pain.0000000000001493","article-title":"Opioid cessation and chronic pain: perspectives of former opioid users","volume":"160","author":"Goesling","year":"2019","journal-title":"Pain"},{"key":"2023120910202707000_13.12.e075246.18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/2049463720974053","article-title":"Hopes and fears before opioid tapering: a quantitative and qualitative study of patients with chronic pain and long-term opioids","volume":"15","author":"Quinlan","year":"2021","journal-title":"Br J Pain"},{"key":"2023120910202707000_13.12.e075246.19","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002336"},{"key":"2023120910202707000_13.12.e075246.20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.sjpain.2017.09.005","article-title":"Opioid tapering in patients with prescription opioid use disorder: A retrospective study","volume":"17","author":"Zhou","year":"2017","journal-title":"Scand J Pain"},{"key":"2023120910202707000_13.12.e075246.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2011.03.006"},{"key":"2023120910202707000_13.12.e075246.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.04.003"},{"key":"2023120910202707000_13.12.e075246.23","doi-asserted-by":"crossref","unstructured":"van der Meer PB , Fuentes JJ , Kaptein AA , et al . Therapeutic effect of Psilocybin in addiction: A systematic review. Front Psychiatry 2023;14:1134454. doi:10.3389\/fpsyt.2023.1134454 Available: http:\/\/www.necf.nl\/afbouwprotocol_opioiden_eerstelijn_20210610.pdf","DOI":"10.3389\/fpsyt.2023.1134454"},{"key":"2023120910202707000_13.12.e075246.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02889.x"},{"key":"2023120910202707000_13.12.e075246.25","doi-asserted-by":"publisher","DOI":"10.1177\/1525822X05279903"},{"key":"2023120910202707000_13.12.e075246.26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jpainsymman.2007.11.006","article-title":"Introduction of a self-report version of the prescription drug use questionnaire and relationship to medication agreement noncompliance","volume":"36","author":"Compton","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"2023120910202707000_13.12.e075246.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.11.003"},{"key":"2023120910202707000_13.12.e075246.28","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"2023120910202707000_13.12.e075246.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.12.019"},{"key":"2023120910202707000_13.12.e075246.30","doi-asserted-by":"crossref","unstructured":"Sud A , Armas A , Cunningham H , et al . Multidisciplinary care for opioid dose reduction in patients with chronic non-cancer pain: A systematic realist review. PLOS ONE 2020;15:e0236419. doi:10.1371\/journal.pone.0236419 Available: https:\/\/doi.org\/10.1371\/journal.pone.0236419","DOI":"10.1371\/journal.pone.0236419"},{"key":"2023120910202707000_13.12.e075246.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2011.09.010"},{"key":"2023120910202707000_13.12.e075246.32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000500807","article-title":"A qualitative approach in understanding illness perception and treatment needs in patients with gamma Hydroxybutyrate use disorder","volume":"25","author":"Beurmanjer","year":"2019","journal-title":"Eur Addict Res"},{"key":"2023120910202707000_13.12.e075246.33","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1111\/add.15401","article-title":"A pilot trial of collaborative care with motivational interviewing to reduce opioid risk and improve chronic pain management","volume":"116","author":"Borsari","year":"2021","journal-title":"Addiction"},{"key":"2023120910202707000_13.12.e075246.34","doi-asserted-by":"crossref","unstructured":"Schellekens AFA , Veldman SE , Suranto ESD , et al . Beneficial effects of opioid rotation to buprenorphine\/naloxone on opioid misuse, craving, mental health, and pain control in chronic non-cancer pain patients with opioid use disorder. J Clin Med 2021;10:3727. doi:10.3390\/jcm10163727 Available: https:\/\/doi.org\/10.3390\/jcm10163727","DOI":"10.3390\/jcm10163727"},{"key":"2023120910202707000_13.12.e075246.35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/j.pain.0000000000002462","article-title":"Effects of opioid rotation to buprenorphine\/naloxone on pain, pain thresholds, pain tolerance, and quality of life in patients with chronic pain and opioid use disorder","volume":"163","author":"Veldman","year":"2022","journal-title":"PAIN"},{"key":"2023120910202707000_13.12.e075246.36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s40429-020-00352-6","article-title":"The impact of chronic pain on opioid use disorder treatment outcomes","volume":"8","author":"MacLean","year":"2021","journal-title":"Curr Addict Rep"},{"key":"2023120910202707000_13.12.e075246.37","doi-asserted-by":"crossref","unstructured":"Amato L , Minozzi S , Davoli M , et al . Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev 2008:CD005031. doi:10.1002\/14651858.CD005031.pub3 Available: https:\/\/doi.org\/10.1002\/14651858.CD005031.pub2","DOI":"10.1002\/14651858.CD005031.pub3"},{"key":"2023120910202707000_13.12.e075246.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.09.012"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-075246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T18:22:43Z","timestamp":1702146163000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-075246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,9]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/bmjopen-2023-075246"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-075246","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}